glp-1 analog weight loss Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Alternative dosing regimens of GLP‐1

Description

Despite inherent limitations of observational data and potential for residual confounding, the results from these observational analyses support, in line with RCT findings, combining SGLT2is and GLP-1RAs to reduce cardiovascular events in patients with diabetes in routine clinical care [12, 23, 43, 63]

Cost-Effectiveness Analysis: Cost per Pound Lost (Estimated): Oral Semaglutide (Rybelsus): Average weight loss: 10 pounds (for 250 lb person) Cost: $900-$1,000/month for 6 months = $5,400-$6,000 Cost per pound lost: $540-$600 Injectable Semaglutide (Compounded from TrimRx): Average weight loss: 37 pounds (for 250 lb person) Cost: $199/month for 16 months = $3,184 Cost per pound lost: $86 Injectable Tirzepatide (Compounded from TrimRx): Average weight loss: 56 pounds (for 250 lb person) Cost: $349/month for 18 months = $6,282 Cost per pound lost: $112 Value Comparison: Hidden Costs: Oral Semaglutide: No injection supplies needed (saves $20-30/month) May require acid reflux medication if SNAC causes irritation Potential need for additional weight loss interventions if not effective Injectable Medications: Injection supplies usually included or inexpensive Sharps container ($5-10 one-time) Potential anti-nausea medication ($10-30/month if needed) Insurance Variables: If your insurance covers Rybelsus with a $25-$50 copay, it may seem like an attractive option